ESC

Treatment of Heart Attack Patients Depends on Cancer History
News | Cardio-oncology | September 26, 2017

September 26, 2017 — Treatment of heart attack patients depends on their history of...

Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension | September 14, 2017

September 14, 2017 — Marijuana use is associated with a three-fold risk of death from...

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics | September 12, 2017

September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed,...

News | Pharmaceuticals | September 12, 2017

September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in...

New FOURIER Analysis Examines How Low Cholesterol Can Safely Go
News | ESC | September 12, 2017

September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with...

CANTOS Study Shows Reducing Inflammation Cuts Cardiovascular Disease, Lung Cancer Risk
News | ESC | September 12, 2017

September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk...

COMPASS Trial Shows Rivaroxaban With Aspirin Improves Stable Cardiovascular Disease
Feature | Antiplatelet and Anticoagulation Therapies | September 12, 2017

September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with...

ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study | September 12, 2017

September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking...

Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study.

Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study presented at ESC 2017.

Feature | ESC | September 07, 2017

September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to...

PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC | September 07, 2017

September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of...

Biotronik's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
News | Stents Drug Eluting | September 01, 2017

September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and...

SPYRAL HTN-OFF MED Study Results Show Efficacy, Safety of Renal Denervation
News | Renal Denervation | August 31, 2017

August 31, 2017 — Medtronic plc announced its intent to move forward with a new...

MobiusHD Device Shows Promise in Treatment of Resistant Hypertension
News | Hypertension | August 30, 2017

August 30, 2017 — Vascular Dynamics Inc. announced interim results of the company’s...

Real-World Analysis Compares Safety, Effectiveness of Apixaban Versus Warfarin
News | Antiplatelet and Anticoagulation Therapies | August 28, 2017

August 28, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. announced results from an analysis of real-world data...

Overlay Init